Treatment B) Drug Therapy-Reference-Cited by-同舟云学术

Treatment B) Drug Therapy

Published:2013 Issue:12 Volume:20 Page:850-860
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Teramoto Tamio,Sasaki Jun,Ishibashi Shun,Birou Sadatoshi,Daida Hiroyuki,Dohi Seitaro,Egusa Genshi,Hiro Takafumi,Hirobe Kazuhiko,Iida Mami,Kihara Shinji,Kinoshita Makoto,Maruyama Chizuko,Ohta Takao,Okamura Tomonori,Yamashita Shizuya,Yokode Masayuki,Yokote Koutaro

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Reference80 articles.

1. 1) Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, Nakaya N, Nishimoto S, Muranaka M, Yamamoto A, Mizuno K, Ohashi Y; for the MEGA Study Group: Primary prevention of cardiovascular disease with pravastatin in Japan(MEGA Study): a prospective randomized controlled trial. Lancet, 2006; 368: 1155-1163

2. 2) Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, Zeiher A, Chaitman BR, Leslie S, Stern T: Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering(MIRACL) Study Investigators: Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA, 2001; 285: 1711-1718

3. 3) Thompson PL, Meredith I, Amerena J, Campbell TJ, Sloman JG, Harris PJ, the Pravastatin in Acute Coronary Treatment(PACT) Investigators: Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: The Pravastatin in Acute Coronary Treatment(PACT) trial. Am Heart J, 2004; 148: e2

4. 4) de Lemos JA, Blazing MA, Wiviott SD, Lewis EF, Fox KA, White HD, Rouleau JL, Pedersen TR, Gardner LH, Mukherjee R, Ramsey KE, Palmisano J, Bilheimer DW, Pfeffer MA, Califf RM, Braunwald E; A to Z Investigators: Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JAMA, 2004; 292: 1307-1316

5. 5) Stenestrand U, Wallentin L: Swedish Register of Cardiac Intensive Care(RIKS-HIA): Early statin treatment fol lowing acute myocardial infarction and 1-year survival. JAMA, 2001; 285: 430-436

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HYPERLIPIDEMIA IN YOUNG AGE: CASE REPORT;INDO AM J PHARM SCI;2019

2. Target of Triglycerides as Residual Risk for Cardiovascular Events in Patients With Coronary Artery Disease　― Post Hoc Analysis of the FMD-J Study A ―;Circulation Journal;2019-04-25

3. Adherence and persistence to hyperlipidemia medications in patients with atherosclerotic cardiovascular disease and those with diabetes mellitus based on administrative claims data in Japan;Atherosclerosis;2019-03

4. Treatment patterns in hyperlipidaemia patients based on administrative claim databases in Japan;Atherosclerosis;2018-05

5. Efficacy and safety of alirocumab in patients with hypercholesterolemia not adequately controlled with non-statin lipid-lowering therapy or the lowest strength of statin: ODYSSEY NIPPON study design and rationale;Lipids in Health and Disease;2017-06-17